These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 31011203)

  • 21. The diabetic patient with renal failure.
    Ritz E; Schömig M
    Nefrologia; 2000; 20 Suppl 3():16-24. PubMed ID: 10835873
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 as predictors of all-cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathy.
    Theilade S; Lajer M; Jorsal A; Tarnow L; Parving HH; Rossing P
    Diabet Med; 2012 Mar; 29(3):337-44. PubMed ID: 21988672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. End-stage renal disease attributable to diabetes mellitus.
    Perneger TV; Brancati FL; Whelton PK; Klag MJ
    Ann Intern Med; 1994 Dec; 121(12):912-8. PubMed ID: 7978716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM.
    Vleming LJ; van der Pijl JW; Lemkes HH; Westendorp RG; Maassen JA; Daha MR; van Es LA; van Kooten C
    Clin Nephrol; 1999 Mar; 51(3):133-40. PubMed ID: 10099885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Coding Variants in Hydroxysteroid 17-beta Dehydrogenase 14 (
    Mychaleckyj JC; Valo E; Ichimura T; Ahluwalia TS; Dina C; Miller RG; Shabalin IG; Gyorgy B; Cao J; Onengut-Gumuscu S; Satake E; Smiles AM; Haukka JK; Tregouet DA; Costacou T; O'Neil K; Paterson AD; Forsblom C; Keenan HA; Pezzolesi MG; Pragnell M; Galecki A; Rich SS; Sandholm N; Klein R; Klein BE; Susztak K; Orchard TJ; Korstanje R; King GL; Hadjadj S; Rossing P; Bonventre JV; Groop PH; Warram JH; Krolewski AS
    J Am Soc Nephrol; 2021 Oct; 32(10):2634-2651. PubMed ID: 34261756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial).
    Schutte E; Lambers Heerspink HJ; Lutgers HL; Bakker SJ; Vart P; Wolffenbuttel BH; Umanath K; Lewis JB; de Zeeuw D; Gansevoort RT
    Am J Kidney Dis; 2015 Sep; 66(3):450-8. PubMed ID: 25987260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of reduced red blood cell deformability and diabetic nephropathy.
    Brown CD; Ghali HS; Zhao Z; Thomas LL; Friedman EA
    Kidney Int; 2005 Jan; 67(1):295-300. PubMed ID: 15610255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic Inflammation and Progression of Diabetic Kidney Disease.
    Furuya F; Ishii T; Kitamura K
    Contrib Nephrol; 2019; 198():33-39. PubMed ID: 30991405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetes-related end-stage renal disease in Austria 1965-2013.
    Prischl FC; Auinger M; Säemann M; Mayer G; Rosenkranz AR; Wallner M; Kramar R;
    Nephrol Dial Transplant; 2015 Nov; 30(11):1920-7. PubMed ID: 25977308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic risk factors affecting mitochondrial function are associated with kidney disease in people with Type 1 diabetes.
    Swan EJ; Salem RM; Sandholm N; Tarnow L; Rossing P; Lajer M; Groop PH; Maxwell AP; McKnight AJ;
    Diabet Med; 2015 Aug; 32(8):1104-9. PubMed ID: 25819010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD.
    Desai AS; Toto R; Jarolim P; Uno H; Eckardt KU; Kewalramani R; Levey AS; Lewis EF; McMurray JJ; Parving HH; Solomon SD; Pfeffer MA
    Am J Kidney Dis; 2011 Nov; 58(5):717-28. PubMed ID: 21820220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rates of progression to end stage renal failure in nephropathy secondary to type 1 and type 2 diabetes mellitus.
    Bruce R; Williams L; Cundy T
    Aust N Z J Med; 1994 Aug; 24(4):390-5. PubMed ID: 7980236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma Copeptin, Kidney Outcomes, Ischemic Heart Disease, and All-Cause Mortality in People With Long-standing Type 1 Diabetes.
    Velho G; El Boustany R; Lefèvre G; Mohammedi K; Fumeron F; Potier L; Bankir L; Bouby N; Hadjadj S; Marre M; Roussel R
    Diabetes Care; 2016 Dec; 39(12):2288-2295. PubMed ID: 27729425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implication of decreased serum complement 3 in patients with diabetic nephropathy.
    Zhang J; Wang Y; Zhang R; Li H; Han Q; Guo R; Wang T; Li L; Liu F
    Acta Diabetol; 2018 Jan; 55(1):31-39. PubMed ID: 29043511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory Mechanisms as New Biomarkers and Therapeutic Targets for Diabetic Kidney Disease.
    Alicic RZ; Johnson EJ; Tuttle KR
    Adv Chronic Kidney Dis; 2018 Mar; 25(2):181-191. PubMed ID: 29580582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvement in nutritional parameters after initiation of chronic hemodialysis.
    Pupim LB; Kent P; Caglar K; Shyr Y; Hakim RM; Ikizler TA
    Am J Kidney Dis; 2002 Jul; 40(1):143-51. PubMed ID: 12087572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipidomic analysis reveals sphingomyelin and phosphatidylcholine species associated with renal impairment and all-cause mortality in type 1 diabetes.
    Tofte N; Suvitaival T; Ahonen L; Winther SA; Theilade S; Frimodt-Møller M; Ahluwalia TS; Rossing P
    Sci Rep; 2019 Nov; 9(1):16398. PubMed ID: 31705008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A panel of novel biomarkers representing different disease pathways improves prediction of renal function decline in type 2 diabetes.
    Pena MJ; Heinzel A; Heinze G; Alkhalaf A; Bakker SJ; Nguyen TQ; Goldschmeding R; Bilo HJ; Perco P; Mayer B; de Zeeuw D; Lambers Heerspink HJ
    PLoS One; 2015; 10(5):e0120995. PubMed ID: 25973922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diabetes mellitus and development of kidney insufficiency].
    Pap I; Reinecke U
    Z Gesamte Inn Med; 1990 Aug; 45(16):485-7. PubMed ID: 2260364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.